Pfizer in talks to buy Seagen

Pfizer is in preliminary talks to acquire drug maker Seagen, the Wall Street Journal reported, citing people familiar with the matter. The report said Seagen has a market value of around $30 billion and is expected to have a premium on that amount, adding that negotiations for a deal are in the preliminary stages.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner